Newmark Advises Havas Health in 254,000-Square-Foot Headquarters Expansion & Extension at 200 Madison Avenue

Newmark (NMRK) advised Havas Health on a 254,118-square-foot headquarters expansion and long-term lease extension at 200 Madison Avenue in Midtown Manhattan.

Rhea-AI Summary

Newmark (NMRK) advised Havas Health on a 254,118-square-foot headquarters expansion and long-term lease extension at 200 Madison Avenue in Midtown Manhattan.

The deal includes a 64,657-square-foot expansion within the building, where Havas has been headquartered for nearly 30 years. Newmark’s David Falk and Jason Greenstein represented Havas Health, while representatives from George Comfort & Sons and partners represented ownership. The 26-story, 750,000-square-foot tower has a newly renovated entrance and lobby and is adding an 11,000-square-foot amenity center. The transaction occurs amid 32.0 million square feet of Manhattan leasing year-to-date through August, with Midtown accounting for 58.5% of tenant demand.

Key Figures

Headquarters transaction size: 254,118 square feet Expansion space: 64,657 square feet

Headquarters transaction size

254,118 square feet

Havas Health headquarters expansion and lease extension

Expansion space

64,657 square feet

Included in the headquarters transaction

Key Terms

floorplates, forward-looking statements, form 10-k

3 terms

floorplates technical

"The property offers flexible floorplates and convenient access to Grand Central Terminal"

Floorplates are the usable square footage on a single floor of an office or commercial building — basically the floor's footprint available for tenants. Investors care because the size and shape of a floorplate influence how easily space can be leased, what types of tenants fit, and how much rent and value the building can command; think of it like the size of a pizza that determines how many slices (tenants) can be served and how flexible the layout can be.

forward-looking statements regulatory

"Statements in this document regarding Newmark that are not historical facts are"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

form 10-k regulatory

"contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, Sept. 9, 2026 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or the "Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations and other owners and occupiers, announces the Company represented Havas Health in a 254,118-square-foot headquarters expansion and lease extension at 200 Madison Avenue in Midtown Manhattan. The transaction includes a 64,657-square-foot expansion and long-term extension for the global communications group.

President, New York Tri-State Region David Falk and Executive Managing Director Jason Greenstein represented Havas Health in the transaction. George Comfort & Sons President and Chief Executive Officer Peter S. Duncan and Head of NYC Leasing Alexander Bermingham represented ownership, a partnership of George Comfort & Sons, Loeb Partners Realty and Jamestown.

Founded in 1835, Havas Health is one of the world's largest global communications groups, operating across more than 100 markets. It has maintained its headquarters at 200 Madison Avenue for nearly three decades.

"Havas Health's decision to expand and extend its commitment at 200 Madison Avenue reflects the enduring appeal of well-located, high-quality workplace environments for leading global companies," said Falk. "We were proud to advise Havas on a transaction that accommodates its continued growth while providing the scale, flexibility and workplace environment to support the business for years to come."

Located in Manhattan's Grand Central district, 200 Madison Avenue is a 26-story, 750,000-square-foot office tower. The owners recently completed a renovation of the property's Madison Avenue entrance and lobby and is developing an 11,000-square-foot indoor-outdoor amenity center featuring executive conference rooms, collaborative and event spaces, a lounge and outdoor sky garden. Built in 1926, the property offers flexible floorplates and convenient access to Grand Central Terminal, Herald Square and Penn Station, as well as multiple subway and bus lines.

The transaction comes amid sustained leasing momentum across Manhattan, where year-to-date leasing reached 32.0 million square feet through August, following nine consecutive months of activity above 3.0 million square feet. Midtown continues to capture the majority of active tenant demand, accounting for 58.5% of requirements by square footage.

About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries ("Newmark"), is a world leading commercial real estate advisor and service provider to large institutional investors and other owners, global corporations and other occupiers, and lenders. Built with purpose and driven by excellence, Newmark's comprehensive platform is uniquely tailored to provide superior outcomes to clients. For the twelve months ended June 30, 2026, Newmark generated revenues of more than $3.6 billion. As of June 30, 2026, Newmark and its business partners together operated from over 195 offices with more than 10,000 professionals across four continents. Learn more at nmrk.com or follow @newmark.

Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are "forward-looking statements" that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company's business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark's Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.

View original content to download multimedia:https://www.prnewswire.com/news-releases/newmark-advises-havas-health-in-254-000-square-foot-headquarters-expansion--extension-at-200-madison-avenue-302872868.html

SOURCE Newmark Group, Inc.